MEDIUM · 5.4

CVE-2023-41150

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is ...

Vulnerability Description

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is using the product.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality
LOW
Integrity
LOW
Availability
NONE

Affected Products

VendorProductVersions
F-RevocrmF-Revocrm>= 7.3, <= 7.3.8

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-41150?

CVE-2023-41150 is a vulnerability with a CVSS score of 5.4 (MEDIUM). F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is ...

How severe is CVE-2023-41150?

CVE-2023-41150 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-41150?

Check the references section above for vendor advisories and patch information. Affected products include: F-Revocrm F-Revocrm.